Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells

Yaoxue Xuebao

Volumn 47, Issue 5, 2012, Pages 594-599

  Peng, You Mei ^a   Wang, Ning ^a,b   Wang, Ya Feng ^a   Han, Li ^a   Zhang, Yan ^a,b   Jiang, Jin Hua ^a,b   Zhou, Yu Bing ^a   Wang, Qing Duan ^a,b  

^a ZHENGZHOU UNIVERSITY   (China)

^b Henan Key Laboratory for Pharmacology of Liver Diseases   (China)

Author keywords

Cepharanthine hydrochloride; K562 ADR cell; Multidrug resistance; P glycoprotein

Indexed keywords

ANTIBODY; CEPHARANTHINE; DOXORUBICIN; GLYCOPROTEIN P; VERAPAMIL;

ARTICLE; ASSAY; CHRONIC MYELOID LEUKEMIA; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZYLISOQUINOLINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; K562 CELLS; P-GLYCOPROTEIN; RHODAMINE 123;

EID: 84863651288     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Shiraga K, Sakaguchi K, Senoh T, et al. Modulation of doxorubicin sensitivity by cyclosporine A in hepatocellular carcinoma cells and their doxorubicin-resistant sublines [J]. J Gastroenterol Hepatol, 2001, 16: 460-466. (Pubitemid 32397660)
2. Baer MR, George SL, Dodge RK, et al. Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720 [J]. Blood, 2002, 100: 1224-1232. (Pubitemid 34864276)
3. Asaumi J, Nishikawa K, Matsuoka H, et al. Direct antitumor effect of cepharanthin and combined effect with adriamycin against Ehrlich ascites tumor in mice [J]. Anticancer Res, 1995, 15: 67-70.
4. Wu J, Suzuki H, Akhand AA, et al. Modes of activation of mitogen-activated protein kinases and their roles in cepharanthine-induced apoptosis in human leukemia cells [J]. Cell Signal, 2002, 14: 509-515. (Pubitemid 34230586)
5. Biswas KK, Tancharoen S, Sarker KP, et al. Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1/2 and the downregulation of Akt [J]. FEBS Lett, 2006, 580: 703-710. (Pubitemid 43089709)
6. Song YC, Xia W, Jiang JH, et al. Reversal of multidrug resistance in drug-resistant cell line EAC/ADR by cepharanthine hydrochloride and its mechanism [J]. Acta Pharm Sin 2005, 40: 204-207. (Pubitemid 40627128)
7. Wu YL, Wang QD. Correlation between reversing effect of cepharanthine on multidrug resistance and bcl-2 in K562/ADR cells [J]. Henan J Oncol 2005, 18: 93-95.
8. Zang CH, Zhang Y, Jiang JH, et al. Effect of cepharanthine hydrochloride on overcoming multidrug resistance and P-gp ATPase activity in mice model of hepatocellular carcinoma [J]. Chin Pharmacol Bull 2011, 27: 1002-1006.
9. Mei X, Jiang YG, Lu JJ, et al. Anti-MDR tumor mechanism of CIP-36, a podophyllotoxin derivative [J]. Acta Pharm Sin 2011,46: 1193-1198.
10. Hovorka O, Subr V, Větvička D, et al. Spectral analysis of doxorubicin accumulation and the indirect quantification of its DNA intercalation [J]. Eur J Pharm Biopharm, 2010, 76: 514-524.
11. Xia ZL, Ying JY, Sun F, et al. Interaction between (E)-2-(4-(diethylamino methyl) benzylidene)-5, 6-dimethoxy-2, 3-dihydroinden-one and P-glycoprotein [J]. Acta Pharm Sin 2007, 42: 1298-1302.
12. Grundy M, Seedhouse C, Russell NH, et al. P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA [J]. BMC Cancer, 2011, 11: 254.
13. Kobayashi M, Katayama T, Ochiai S, et al. High-dose cepharanthin therapy of idiopathic thrombocytopenic purpura [J]. Rinsho Ketsueki, 1992, 33: 405-407.
14. Loetchutinat C, Saengkhae C, Marbeuf-Gueye C, et al. New insights into the P-glycoprotein-mediated effluxes of rhodamines [J]. Eur J Biochem, 2003, 270: 476-485. (Pubitemid 36177314)
15. Kelly RJ, Draper D, Chen CC, et al. A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer [J]. Clin Cancer Res, 2011, 17: 569-580.
16. Muller C, Goubin F, Ferrandis E, et al. Evidence for transcriptional control of human mdrl gene expression by verapamil in multidrug-resistant leukemic cells [J]. Mol Pharmacol, 1995, 47: 51-56.
17. Muller C, Bailly JD, Goubin F, et al. Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines [J]. Int J Cancer, 1994, 56: 749-754.
18. Wang SY, Yang ZJ, He AG, et al. Study of reversal of KB v200 by verapamine [J]. J China Med Univ 1998,27:243-245.